Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature

The prognosis and optimal management of pN0/pN1 patients with persistently elevated prostate-specific antigen (PSA) 6–8 wk after radical prostatectomy (RP) remain unclear. To perform a systematic review of oncologic outcomes and effectiveness of salvage therapies in men with a detectable PSA level after RP. A systematic review was performed in May 2020. A total of 2374 articles were screened, and 25 studies including 5217 men were selected and...